The impact of a genomic sequencing classifier (GSC) on clinical decision making in patients with a high-risk lung nodule.

8549Background: Current guidelines recommend that patients who have lung nodules with high risk of malignancy (ROM) ( > 65%) should undergo surgical and other ablative therapies. However, prior stu...